Investing.com - Pfizer (NYSE:PFE) reported third quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $0.75 on revenue of $12.68B. Analysts polled by Investing.com expected EPS of $0.62 on revenue of $12.27B. That compared to EPS of $0.78 on revenue of $13.3B in the same period a year earlier. The company had reported EPS of $0.8 on revenue of $13.26B in the previous quarter.
For the year, Pfizer shares are down 14.59%, under-performing the S&P Global (NYSE:SPGI) 100 which is up 19.12% year to date.
Pfizer follows other major Healthcare sector earnings this month
On Tuesday, October 15, 2019, J&J reported third quarter EPS of $2.12 on revenue of $20.73B, compared to forecasts of EPS of $2.01 on revenue of $20.08B.
Merck&Co earnings beat analyst's expectations on Tuesday, with third quarter EPS of $1.51 on revenue of $12.4B. Investing.com analysts expected EPS of $1.24 on revenue of $11.65B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar